• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Rabbit DRAK2 (CT) Antibody

Scan QR to view Datasheet
Catalog # MBS194077
Unit / Price
  0.1 mg  /  $400 +1 FREE 8GB USB
anti-DRAK2 (CT) antibody
Product Name

DRAK2 (CT), Antibody

Also Known As

Anti-DRAK2 (CT) Antibody

Product Synonym Names
Anti-DRAK2 (CT); DRAK2 (CT)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Host
Rabbit
Specificity
Anti-DRAK2 (CT) [Rabbit antibody to peptide corresponding to aa 351-365 of human DRAK2.]
This antibody recognizes human DRAK2 (45 kD). No cross-reactivity with DRAK1, DAP or ZIP kinases.
Form/Format
100 ug IgG in PBS, pH 7.4, purified by immunoaffinity chromatography.
Antigen
Peptide corresponding to aa 351- 365 of human DRAK2.
Stabilizer
None
Preservatives
0.02% sodium azide.
Dilutions Instructions
Dilute in PBS or medium which is identical to that used in the assay system
Preparation and Storage
This antibody is stable for at least one (1) year at -20 degree C. Avoid multiple freeze-thaw cycles.
Other Notes
Small volumes of anti-DRAK2 (CT) antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-DRAK2 (CT) antibody
Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase -related apoptosis-inducing protein kinases. DRAKs contain an Nterminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases which mediate apoptosis through their catalytic activities. DRAK2 is located in cell nuclei, and the mRNA for DRAK2 is ubiquitously expessed in human tissues.
Product Categories/Family for anti-DRAK2 (CT) antibody
Applications Tested/Suitable for anti-DRAK2 (CT) antibody
Immunoblot
Application Notes for anti-DRAK2 (CT) antibody
Immunoblotting : use at 1:500-1:1,000 dilution.
Positive control: Whole cell lysate from Jurkat cells.
NCBI/Uniprot data below describe general gene information for DRAK2 (CT). It may not necessarily be applicable to this product.
NCBI GI #
NCBI Official Full Name
DRAK2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000